Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2899712 | Chest | 2016 | 11 Pages |
Abstract
For the first time, using data from large randomized controlled trials, this study characterizes the different phenotype and outcomes of older patients with PAH, which includes different disease etiology, diminished functional status, and decreased response to intervention. This may have significant implications for the management of this patient population and design of future therapy trials.
Keywords
PAHRegistry to Evaluate Early and Long-Term PAH Disease ManagementPDE-5imPAP6MWDCTD6-min walk distancePAWPEndothelin receptor antagonistsTrustPhosphodiesterase type 5 inhibitorsConnective tissue diseaseWorld Health OrganizationAgePVRERAOutcomesREVEALPulmonary arterial hypertensionmean pulmonary artery pressurePulmonary artery wedge pressurePulmonary vascular resistancePulmonary hypertensionTriumphWHO
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Jonathan A. MS, Jody M. MS, Youlan PhD, Omar A. MD, Adriano R. MD,